Last 47 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 32.79 | 23.85 | 42.56 | 39.94 | 41.63 | 43.19 | 55.07 | 63.84 | 41.81 | 39.75 | 43.64 | 25.12 | 37.95 | 39.73 | 46.34 | 41.58 | 23.66 | 28.91 | 79.57 | 38.64 | 57.83 |
| — | -44.8% | -22.7% | -37.4% | -0.4% | +8.7% | +26.2% | +154.1% | +10.2% | +0.1% | -5.8% | -39.6% | +60.4% | +37.4% | -41.8% | +7.6% | -59.1% | -31.0% | +3.2% | -6.0% | +81.0% | |
| P/S Ratio | 4.20 | 4.61 | 5.27 | 4.74 | 5.90 | 6.35 | 6.13 | 5.40 | 6.34 | 6.05 | 6.57 | 4.94 | 5.34 | 5.86 | 5.72 | 4.49 | 4.32 | 4.23 | 5.98 | 5.44 | 6.07 |
| — | -27.3% | -14.0% | -12.3% | -6.9% | +5.0% | -6.7% | +9.3% | +18.6% | +3.2% | +14.8% | +10.0% | +23.8% | +38.5% | -4.3% | -17.5% | -28.8% | -26.8% | +1.8% | -0.7% | +14.4% | |
| P/B Ratio | 4.70 | 5.07 | 5.53 | 6.06 | 6.56 | 7.21 | 6.87 | 6.74 | 6.91 | 6.64 | 7.19 | 6.18 | 5.86 | 6.75 | 6.47 | 5.63 | 4.70 | 4.85 | 6.80 | 6.88 | 7.12 |
| — | -29.8% | -19.6% | -10.1% | -5.1% | +8.7% | -4.4% | +9.0% | +18.0% | -1.6% | +11.0% | +9.9% | +24.8% | +39.1% | -4.8% | -18.2% | -34.0% | -32.5% | -1.2% | -3.7% | +16.7% | |
| P/FCF | 24.65 | 28.69 | 76.51 | 18.11 | 26.41 | 41.18 | 283.14 | 20.87 | 26.71 | 68.16 | 931.19 | 20.78 | 29.08 | 54.63 | 86.82 | 28.67 | 25.74 | 49.24 | 304.51 | 32.22 | 31.42 |
| — | -30.3% | -73.0% | -13.2% | -1.1% | -39.6% | -69.6% | +0.4% | -8.2% | +24.8% | +972.6% | -27.5% | +13.0% | +10.9% | -71.5% | -11.0% | -18.1% | +53.1% | +383.4% | +47.9% | +20.6% | |
| EV / EBITDA | 19.39 | 21.15 | 28.19 | 16.27 | 26.75 | 25.29 | 27.37 | 19.39 | 25.65 | 25.07 | 29.47 | 18.73 | 23.20 | 24.41 | 27.19 | 18.15 | 20.28 | 19.16 | 28.13 | 21.14 | 24.63 |
| — | -16.4% | +3.0% | -16.1% | +4.3% | +0.9% | -7.1% | +3.5% | +10.6% | +2.7% | +8.4% | +3.2% | +14.4% | +27.4% | -3.3% | -14.1% | -17.7% | -18.1% | +8.4% | +6.3% | +28.4% | |
| EV / EBIT | 24.12 | 21.15 | 34.91 | 21.61 | 38.19 | 35.66 | 51.99 | 70.78 | 36.30 | 35.57 | 40.33 | 25.59 | 33.45 | 35.92 | 44.65 | 34.54 | 27.31 | 30.85 | 74.78 | 25.73 | 56.27 |
| — | -40.7% | -32.9% | -69.5% | +5.2% | +0.3% | +28.9% | +176.6% | +8.5% | -1.0% | -9.7% | -25.9% | +22.5% | +16.4% | -40.3% | +34.2% | -51.5% | -25.9% | +5.3% | -34.2% | +104.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 68.3% | 63.3% | 65.2% | 63.6% | 62.3% | 62.7% | 62.0% | 61.8% | 61.3% | 60.9% | 61.1% | 61.5% | 60.8% | 60.1% | 59.1% | 59.2% | 59.8% | 60.6% | 62.3% | 63.0% |
| — | +9.6% | +0.9% | +5.2% | +3.0% | +1.6% | +3.0% | +1.4% | +0.4% | +0.8% | +1.4% | +3.5% | +4.0% | +1.7% | -0.9% | -5.2% | -6.1% | -4.3% | -0.4% | +0.4% | +0.3% | |
| Operating Margin | 19.5% | 25.2% | 15.5% | 27.3% | 18.7% | 22.6% | 20.1% | 25.8% | 22.0% | 21.4% | 19.1% | 24.5% | 20.2% | 21.3% | 18.0% | 23.0% | 19.0% | 20.2% | 18.3% | 23.2% | 21.5% |
| — | +11.4% | -22.6% | +5.8% | -14.8% | +5.8% | +5.1% | +5.4% | +8.9% | +0.3% | +6.5% | +6.7% | +6.5% | +5.6% | -2.1% | -0.9% | -12.0% | -7.6% | -0.4% | -9.8% | -12.4% | |
| Net Margin | 12.9% | 19.4% | 12.4% | 11.8% | 14.2% | 14.7% | 11.1% | 8.5% | 15.2% | 15.2% | 15.0% | 19.7% | 14.1% | 14.8% | 12.4% | 10.8% | 18.2% | 14.6% | 7.6% | 14.1% | 10.5% |
| — | +31.9% | +11.0% | +39.6% | -6.6% | -3.5% | -25.8% | -56.8% | +7.7% | +3.0% | +21.3% | +81.6% | -22.6% | +1.2% | +64.0% | -23.1% | +73.0% | +5.9% | -1.1% | +5.7% | -36.6% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.1% | 5.4% | 3.3% | 3.8% | 4.0% | 4.2% | 3.1% | 2.7% | 4.2% | 4.2% | 4.2% | 6.3% | 3.9% | 4.3% | 3.5% | 3.4% | 5.1% | 4.3% | 2.2% | 4.6% | 3.1% |
| — | +29.5% | +4.3% | +43.5% | -4.3% | -1.0% | -24.6% | -57.3% | +6.5% | -1.6% | +18.1% | +84.0% | -22.7% | +0.9% | +63.7% | -25.3% | +62.3% | -1.4% | -5.0% | +4.6% | -35.2% | |
| ROA | 7.1% | 2.7% | 1.6% | 1.8% | 1.8% | 1.9% | 1.5% | 1.3% | 2.0% | 2.1% | 2.0% | 2.9% | 1.8% | 2.0% | 1.6% | 1.5% | 2.3% | 1.8% | 0.9% | 1.9% | 1.3% |
| — | +41.5% | +7.7% | +42.2% | -8.5% | -8.9% | -26.0% | -57.1% | +9.6% | +5.7% | +23.7% | +89.8% | -19.1% | +9.4% | +76.0% | -19.7% | +75.5% | +3.1% | +2.4% | +12.9% | -33.7% | |
| ROIC | 11.1% | 3.5% | 2.0% | 4.2% | 2.4% | 2.8% | 2.6% | 3.9% | 2.9% | 2.9% | 2.5% | 3.7% | 2.5% | 2.7% | 2.3% | 3.2% | 2.2% | 2.4% | 2.2% | 3.3% | 2.7% |
| — | +25.0% | -24.1% | +5.6% | -17.8% | -0.5% | +4.0% | +7.4% | +13.6% | +4.0% | +12.4% | +15.6% | +13.0% | +14.4% | +1.7% | -4.0% | -17.5% | -15.5% | +0.2% | -11.6% | -23.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.73 | 0.59 | 0.66 | 0.73 | 0.80 | 0.81 | 0.83 | 0.68 | 0.79 | 0.64 | 0.70 | 0.73 | 0.74 | 0.77 | 0.80 | 0.81 | 0.80 | 0.88 | 0.97 | 0.87 | 0.92 |
| — | -26.8% | -20.1% | +6.6% | +1.2% | +25.3% | +18.6% | -5.7% | +7.8% | -16.7% | -12.9% | -10.8% | -8.3% | -12.4% | -17.3% | -6.1% | -12.8% | -7.2% | -3.0% | -21.3% | -11.7% | |
| Debt / EBITDA | 2.69 | 9.07 | 12.33 | 7.18 | 11.92 | 10.34 | 11.96 | 7.33 | 10.84 | 9.00 | 10.61 | 8.06 | 10.53 | 10.15 | 12.16 | 9.34 | 12.03 | 11.95 | 14.23 | 9.71 | 11.54 |
| — | -12.2% | +3.0% | -1.9% | +9.9% | +14.9% | +12.7% | -9.0% | +3.0% | -11.4% | -12.8% | -13.8% | -12.5% | -15.0% | -14.5% | -3.8% | +4.2% | +7.0% | +5.8% | -11.2% | -4.7% | |
| Current Ratio | 1.89 | 2.16 | 2.11 | 1.89 | 1.85 | 1.78 | 1.64 | 1.95 | 1.91 | 1.68 | 1.71 | 1.58 | 1.48 | 1.54 | 1.73 | 1.63 | 2.04 | 2.00 | 1.98 | 2.20 | 2.13 |
| — | +20.9% | +28.6% | -2.9% | -3.3% | +6.1% | -3.9% | +23.4% | +29.2% | +9.1% | -1.2% | -3.1% | -27.4% | -23.1% | -12.5% | -26.0% | -4.1% | -5.7% | -12.9% | +14.4% | -26.4% | |
| Quick Ratio | 1.21 | 1.33 | 1.25 | 1.21 | 1.13 | 1.06 | 1.00 | 1.32 | 1.22 | 0.95 | 0.99 | 0.97 | 0.83 | 0.84 | 0.99 | 1.00 | 1.19 | 1.15 | 1.18 | 1.47 | 1.35 |
| — | +25.8% | +25.6% | -8.4% | -8.0% | +11.1% | +1.1% | +36.5% | +48.1% | +12.9% | -0.5% | -2.8% | -30.5% | -26.8% | -15.9% | -32.4% | -12.2% | -12.5% | -15.3% | +19.6% | -37.0% | |
| Interest Coverage | 8.44 | — | 6.74 | 4.50 | 6.55 | 7.39 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SYK stock.
Stryker Corporation's current P/E is 32.8x. The average P/E over the last 4 quarters is 37.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Stryker Corporation's current operating margin is 19.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Stryker Corporation's business trajectory between earnings reports.